Improving Access to HCV Care in Key Populations

Review data on improving hepatitis C care in vulnerable populations by increasing access to care and streamlining testing and diagnosis.
Stacey Trooskin, MD, PhD, MPH
Format: Microsoft PowerPoint (.ppt)
File Size: 2.60 MB
Released: November 2, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AbbVie

Related Content

Download key slides describing lessons learned in delivery of care from the COVID-19 pandemic worth carrying forward in the management of viral hepatitis.

Gregory Dore, MBBS, PhD, FRACP, MPH Stacey Trooskin, MD, PhD, MPH Released: September 23, 2021

Dr. Stacey Trooskin discusses the implementation of the simplified HCV treatment model, presented by Clinical Care Options (CCO)

Stacey Trooskin, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 31, 2021 Expired: August 30, 2022

Dr Stacey Trooskin discusses how to reduce barriers to HCV care using simplified management algorithms, presented by Clinical Care Options (CCO)

Stacey Trooskin, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 6, 2021 Expired: August 5, 2022

Top EASL 2021 studies from Clinical Care Options (CCO) and Stefan Zeuzem: HBV Cure, HCV point-of-care testing and treatment cascade, utility of SVR4, emerging HDV treatments

Stefan Zeuzem, MD Released: July 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue